106 related articles for article (PubMed ID: 16019550)
1. The ratio between CD4+ and CD8+ cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomide.
Strupp C; Germing U; Aivado M; Kündgen A; Fenk R; Hünerlitürkoglu A; Kobbe G; Haas R; Gattermann N
Leuk Lymphoma; 2005 Jul; 46(7):999-1006. PubMed ID: 16019550
[TBL] [Abstract][Full Text] [Related]
2. [Effects of thalidomide on CD4(+)CD25(+) T regulatory cells in patients with multiple myeloma].
Yang Y; Zhang WG; He AL; Yang HY; Wang JL; Tian W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):538-42. PubMed ID: 18549624
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of Lymphocyte Subsets in Peripheral Blood of Patients with Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome].
Lv YF; Yan ZY; Chen NY; Wu JH; Liu B; Wang GL; Wang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1505-1510. PubMed ID: 27784383
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma.
Herth I; Witzens-Harig M; Beckhove P; Hose D; Meissner T; Neuber B; Engelhardt M; Haas J; Neben K; Ho AD; Klein B; Goldschmidt H; Hundemer M
Exp Hematol; 2013 Mar; 41(3):231-40. PubMed ID: 23142220
[TBL] [Abstract][Full Text] [Related]
5. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
[TBL] [Abstract][Full Text] [Related]
6. Properties of thalidomide and its analogues: implications for anticancer therapy.
Teo SK
AAPS J; 2005 Mar; 7(1):E14-9. PubMed ID: 16146335
[TBL] [Abstract][Full Text] [Related]
7. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
8. In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
Schütt P; Buttkereit U; Brandhorst D; Lindemann M; Schmiedl S; Grosse-Wilde H; Seeber S; Nowrousian MR; Opalka B; Moritz T
Cancer Immunol Immunother; 2005 May; 54(5):506-12. PubMed ID: 15750834
[TBL] [Abstract][Full Text] [Related]
9. [Expression of T cell markers in hematological diseases and solid tumor].
Miao XY; Jia L; Wang YC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):79-82. PubMed ID: 14989775
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide: a novel template for anticancer drugs.
Stirling D
Semin Oncol; 2001 Dec; 28(6):602-6. PubMed ID: 11740817
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide for the treatment of myelodysplastic syndrome in Taiwan: results of a phase II trial.
Chung CY; Lin SF; Chen PM; Chang MC; Kao WY; Chao TY; Hsiao LT; Yen CC; Yang MH; Hwang WS; Lin TL; Chiou TJ; Chang CS
Anticancer Res; 2012 Aug; 32(8):3415-9. PubMed ID: 22843924
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide for the treatment of idiopathic myelofibrosis.
Strupp C; Germing U; Scherer A; Kündgen A; Mödder U; Gattermann N; Haas R
Eur J Haematol; 2004 Jan; 72(1):52-7. PubMed ID: 14962263
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
15. [Perioperative changes of cellular immune response of patients with esophageal carcinoma evaluated through detecting AgNOR content in peripheral blood T lymphocytes and T cell subsets].
Wang JY; Dai SQ; Ye WF; Long H; Lin P; Li BJ; Rong TH
Ai Zheng; 2005 Jul; 24(7):861-4. PubMed ID: 16004816
[TBL] [Abstract][Full Text] [Related]
16. [Thalidomide in treatment of connective diseases and vasculities].
Maruotti N; Cantatore FP; Ribatti D
Reumatismo; 2006; 58(3):187-90. PubMed ID: 17013434
[TBL] [Abstract][Full Text] [Related]
17. [Thalidomide: mechanisms of action and new insights in hematology].
Leleu X; Micol JB; Guieze R; Berthon C; Kuhnovsky F; Terriou L; Moreau AS; Yakoub-Agha I; Bauters F; Facon T
Rev Med Interne; 2005 Feb; 26(2):119-27. PubMed ID: 15710258
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
19. Normal values of CD4 and CD8 lymphocyte subsets in healthy indian adults and the effects of sex, age, ethnicity, and smoking.
Uppal SS; Verma S; Dhot PS
Cytometry B Clin Cytom; 2003 Mar; 52(1):32-6. PubMed ID: 12599179
[TBL] [Abstract][Full Text] [Related]
20. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Baron F; Schaaf-Lafontaine N; Humblet-Baron S; Meuris N; Castermans E; Baudoux E; Frère P; Bours V; Fillet G; Beguin Y
Transplantation; 2003 Dec; 76(12):1705-13. PubMed ID: 14688520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
